First CAR T-Cell Therapies OK'd In EU: Novartis's Kymriah And Kite's Yescarta

 
• By Ian Schofield and Neena Brizmohun
  
Recommended
The CHMP has recommended nine products for marketing authorization in the EU
Pink Sheet Podcast

Have you checked out Pink Sheet podcast?

New episodes every Thursday.

SpotifyApple PodcastsWebsite

More from Approvals

More from Product Reviews